B002 in Patients With HER2-positive Breast Cancer

NCT04382352 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Breast Cancer
Metastatic Breast Cancer

Interventions

BIOLOGICAL: Humanized Anti-HER2 Monoclonal Antibody Compound for Injection .R&D code: B002.

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd